News

Video

ASCRS 2024: CoFi CEO gives insight into company's integration with CareCredit

Sean Hanlon, CEO of CoFi, a payment software company, talks about the company's recent integration with CareCredit.

Sean Hanlon:

Hi, I'm Sean Hanlon. I'm the CEO of CoFi. CoFi is a payment software company that enables patients to pay multiple providers involved in a surgery at one time. And we're really excited to be here at ASCRS and ASOA in Boston. We're based in Boston, so we're excited that the show is here, and it's great to see everybody.

A couple things that we're particularly excited about. Number one is we have announced the launch of our new integration with CareCredit. We're enabling multi-party or multi-provider patient financing, so patients can finance an entire procedure, including the surgeons' fees and any of their surgical partners' fees, like a surgery center, or a comanaging optometrist, and so on. The patient can have a single financing event. Those other partners just simply need to have a CoFi account in order to receive their funds. And so both CoFi and CareCredit are excited about this partnership, and excited to launch it; nationally, it's now commercially available.

The other thing we're excited about is CoFi, since we launched our company and launched our product, I should say, just under 3 years ago, we've now eclipsed 5,000 ophthalmologists and optometrists on our platform, a number that's growing by the hundreds every month. I think that's a testament to the fact that we've built, you know, a product that's solving some real needs in the market around payment compliance and payment convenience for patients, and convenience and sort of reduction of administrative burden for practices. So, always excited to come to ASCRS, and particularly excited this year. Hope to see folks while they're here or connect with you after the meeting. Thank you

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.